Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33216 | 127 | 25.4 | 32% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1745167 |
346 | 3 | CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN | 36072 |
2227 | 2 | CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN | 4791 |
33216 | 1 | BIMOLANE//PROBIMANE//MST 16 | 127 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BIMOLANE | authKW | 1178140 | 6% | 70% | 7 |
2 | PROBIMANE | authKW | 751364 | 4% | 63% | 5 |
3 | MST 16 | authKW | 427440 | 3% | 44% | 4 |
4 | BISDIOXOPIPERAZINE COMPOUNDS | authKW | 320582 | 2% | 67% | 2 |
5 | CATIONIZED POLYACRYLAMIDE | authKW | 320582 | 2% | 67% | 2 |
6 | 1 BETA D ARABINOFURANOSYL 2 THIOCYTOSINE ARASC | authKW | 240438 | 1% | 100% | 1 |
7 | 337 OHIZUMI MACHI 2 CHOME NERIMA KU | address | 240438 | 1% | 100% | 1 |
8 | 4 4 1 2 ETHANEDIYLBIS 1 ISOBUTOXYCARBONYLOXYMETHYL 2 6 PIPERAZINEDIONE | authKW | 240438 | 1% | 100% | 1 |
9 | ANGIODYNAMICS | authKW | 240438 | 1% | 100% | 1 |
10 | BIS 2 6 DIOXOPIPERAZINE | authKW | 240438 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 687 | 39% | 0% | 49 |
2 | Pharmacology & Pharmacy | 87 | 17% | 0% | 22 |
3 | Medicine, General & Internal | 75 | 13% | 0% | 16 |
4 | Dermatology | 39 | 5% | 0% | 6 |
5 | Hematology | 21 | 5% | 0% | 6 |
6 | Chemistry, Multidisciplinary | 20 | 11% | 0% | 14 |
7 | Demography | 10 | 1% | 0% | 1 |
8 | Chemistry, Medicinal | 8 | 3% | 0% | 4 |
9 | Toxicology | 8 | 3% | 0% | 4 |
10 | Multidisciplinary Sciences | 8 | 2% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 337 OHIZUMI MACHI 2 CHOME NERIMA KU | 240438 | 1% | 100% | 1 |
2 | HADASSAH MT | 240438 | 1% | 100% | 1 |
3 | HAEMOSTASIS THROMBOSIS VASC BIOL | 120218 | 1% | 50% | 1 |
4 | MED 31 | 120218 | 1% | 50% | 1 |
5 | IMPERIAL CANC FUND MED ONCOL UNIT | 40071 | 1% | 17% | 1 |
6 | PERINATAL PATHOL UNIT | 26714 | 1% | 11% | 1 |
7 | MORPHOGENESE SIGNALISAT CELLULAI | 7754 | 1% | 3% | 1 |
8 | MODELADO MOL BIOINFORMAT | 5723 | 1% | 2% | 1 |
9 | UAB COMPREHENS CANC | 3697 | 1% | 2% | 1 |
10 | UNIDAD SERV OYO OLUC ANALIT | 3534 | 1% | 1% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA PHARMACOLOGICA SINICA | 5160 | 9% | 0% | 11 |
2 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2028 | 2% | 0% | 3 |
3 | CANCER CLINICAL TRIALS | 1876 | 1% | 1% | 1 |
4 | RECENT RESULTS IN CANCER RESEARCH | 1831 | 2% | 0% | 2 |
5 | ACTA HAEMATOLOGICA JAPONICA | 1296 | 2% | 0% | 2 |
6 | CANCER TREATMENT REVIEWS | 1110 | 2% | 0% | 3 |
7 | CLINICAL & EXPERIMENTAL METASTASIS | 1080 | 2% | 0% | 3 |
8 | BRITISH JOURNAL OF HOSPITAL MEDICINE | 954 | 3% | 0% | 4 |
9 | CHEMIJA | 745 | 1% | 0% | 1 |
10 | NEW YORK STATE JOURNAL OF MEDICINE | 636 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LU, DY , LU, TR , (2010) ANTIMETASTATIC ACTIVITIES AND MECHANISMS OF BISDIOXOPIPERAZINE COMPOUNDS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 7. P. 564-570 | 13 | 30% | 2 |
2 | HELLMANN, K , (2003) DYNAMICS OF TUMOUR ANGIOGENESIS: EFFECT OF RAZOXANE-INDUCED GROWTH RATE SLOWDOWN.CLINICAL & EXPERIMENTAL METASTASIS. VOL. 20. ISSUE 2. P. 95-102 | 9 | 50% | 13 |
3 | LU, DY , LU, TR , (2010) ANTICANCER ACTIVITIES AND MECHANISMS OF BISDIOXOPIPERAZINE COMPOUNDS PROBIMANE AND MST-16.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 1. P. 78-91 | 11 | 32% | 0 |
4 | LU, DY , LU, DR , DING, JA , (2010) CELL BIOLOGICAL MANIFESTATIONS OF BISDIOXOPIPERAZINES: TREATMENT OF HUMAN TUMOR CELL LINES IN CULTURE.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 9. P. 657 -660 | 8 | 32% | 0 |
5 | CHEN, SQ , XUE, KX , WU, JZ , MA, GJ , (1995) MUTAGENIC EFFECTS OF BIMOLANE.ACTA PHARMACOLOGICA SINICA. VOL. 16. ISSUE 6. P. 531-533 | 4 | 67% | 3 |
6 | MANCILLA, T , CARRILLO, L , ZAMUDIO-RIVERA, LS , BELTRAN, HI , FARFAN, N , (2002) SYNTHESIS AND CHARACTERIZATION OF PIPERAZINE-2,6-DIONES.ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL. VOL. 34. ISSUE 1. P. 87-94 | 5 | 38% | 7 |
7 | HE, SQ , LI, CF , ZHEN, XY , ZHOU, J , LIU, TF , (1989) RADIATION SURVIVAL PROPERTIES OF CULTURED HUMAN GASTRIC ADENOCARCINOMA CELLS AND THE EFFECT OF AT-1727.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 16. ISSUE 2. P. 361-368 | 7 | 47% | 0 |
8 | GE, F , ZHANG, YM , CAO, FL , LI, JM , HOU, JX , WANG, P , LI, HT , XU, MY , LIU, SC , LI, LM , ET AL (2016) ARSENIC TRIOXIDE-BASED THERAPY IS SUITABLE FOR PATIENTS WITH PSORIASIS-ASSOCIATED ACUTE PROMYELOCYTIC LEUKEMIA - A RETROSPECTIVE CLINICAL STUDY.HEMATOLOGY. VOL. 21. ISSUE 5. P. 287 -294 | 4 | 31% | 0 |
9 | GILBERT, JM , THOMPSON, EM , SLAVIN, G , KARK, AE , (1984) INHIBITION OF EXPERIMENTAL COLORECTAL-CANCER BY RAZOXANE (ICRF-159).BRITISH JOURNAL OF SURGERY. VOL. 71. ISSUE 8. P. 600-603 | 4 | 100% | 3 |
10 | VUONG, MC , HASEGAWA, LS , EASTMOND, DA , (2013) A COMPARATIVE STUDY OF THE CYTOTOXIC AND GENOTOXIC EFFECTS OF ICRF-154 AND BIMOLANE, TWO CATALYTIC INHIBITORS OF TOPOISOMERASE II.MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS. VOL. 750. ISSUE 1-2. P. 63-71 | 9 | 14% | 2 |
Classes with closest relation at Level 1 |